Colorectal Cancer Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Veröffentlicht von: precision business insights
Veröffentlicht am: 06.02.2018 11:06
Rubrik: Gesundheit & Medizin


(Presseportal openBroadcast) - Colorectal Cancer Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Pressekontakt:

Colorectal cancer is also known as bowel cancer. It refers to the abnormal growth of the cells in colon and rectum due to cancer. Colorectal cancer starts either in the colon and rectum. Cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Some of the risk factors that can cause colorectal cancer are lifestyle changes, old age, genetic disorders, family history, and inflammatory bowel disease. Some of the symptoms of colorectal cancer are blood in stool, decrease in appetite, constipation, weight loss, nausea, bloating, and pelvic pain.
Global colorectal cancer market is driven by some of the major factors such as increasing prevalence of colorectal cancer, technological advancements in the cancer therapy, aging population, and raise in consumer awareness about colorectal cancers. However, high costs of screening tests and drugs, lack of knowledge are some of the restraints that are hampering the growth of the global colorectal cancer drugs market.
A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-colorectal-cancer-drugs-market/#ulp-4H8Z4LpNMLEuOnnx

The global colorectal cancer drugs market is segmented by therapy, drug class, distribution channel, and regions.
On the basis of therapy, global colorectal cancer drugs market is segmented as
• Adjuvant chemotherapy
• Palliative chemotherapy
• Immuno therapy
• Neo adjuvant chemotherapy

On the basis of drug class, global colorectal cancer drugs market is segmented as
• Capecitabine (Xeloda)
• Irinotecan (Camptosar)
• Fluorouracil (5-FU, Adrucil)
• Trifluridine/tipiracil (TAS-102, Lonsurf)
• Oxaliplatin (Eloxatin)
• Others

Some common treatment regimens using these drugs include:
• 5-FU
• Capecitabine, an oral form of 5-FU
• 5-FU with leucovorin (Wellcovorin), a vitamin that improves the effectiveness of 5-FU
• FOLFIRI: 5-FU with leucovorin and irinotecan
• FOLFOX: 5-FU with leucovorin and oxaliplatin
• Irinotecan alone
• XELOX/CAPEOX: Capecitabine with oxaliplatin
• XELIRI/CAPIRI: Capecitabine with irinotecan

On the basis of distribution channel, the global colorectal cancer drugs market is segmented as
• Retail Pharmacies
• Hospital Pharmacies
• Others
To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-colorectal-cancer-drugs-market/#ulp-c654SbFYO64MsOhu
Colorectal cancer is the third most common cancer in the world. Huge government initiatives taken by the nations are booming up the growth of the colorectal cancer drugs treatment market globally. Biologics such as Zaltrap (Ziv-Aflibercept), Erbitux (Cetuximab), Avastin (Bevacizumab) are using rapidly for the treatment for colorectal cancer that are used as a targeted therapy and they acts only on the malignant cells. Market players in the colorectal cancer drugs market forming strategic alliances and partnerships to increase their market share.
Geographically, global colorectal cancer treatment market is segmented into five key regions such as Latin America, North America, Asia-Pacific, Europe and The Middle East and Africa. North America expected to grow at significant rate in colorectal cancer drugs market owing to the growing incidence of colorectal cancer and widespread awareness about early diagnosis and treatment of colorectal cancer. Asia Pacific region expected to have rapid growth in the market during the forecast period owing to huge population densities and high incidence of colorectal cancer in countries such as India and China.

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-colorectal-cancer-drugs-market/#ulp-14mlyhjMGhVjZqa3
Some of the players in the colorectal cancer drugs market are Amgen Inc. (U.S), Bristol-Myers Squibb Company (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Bayer AG (Germany), Merck & Co., Inc. (U.S.), and Sanofi (France) to name a few.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-colorectal-cancer-drugs-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com


Bitte beachten Sie, dass für den Inhalt der hier veröffentlichten Meldung nicht openBroadcast verantwortlich ist, sondern der Verfasser der jeweiligen Meldung selbst. AGB | Haftungsausschluss.